Your institution may have access to this item. Find your institution then sign in to continue.
Title
A randomised phase II study of modified FOLFIRI.3 vs modified FOLFOX as second-line therapy in patients with gemcitabine-refractory advanced pancreatic cancer.
Authors
C. Yoo; J. Y. Hwang; J.-E. Kim; T. W. Kim; J. S. Lee; D. H. Park; S. S. Lee; D. W. Seo; S. K. Lee; M.-H. Kim; D. J. Han; S. C. Kim; J.-L. Lee; Yoo, C; Hwang, J Y; Kim, J-E; Kim, T W; Lee, J S; Park, D H; Lee, S S
Publication
British Journal of Cancer, 2009, Vol 101, Issue 10, p1658